Walking and Recovery After Lung Cancer Surgery (AIRTECH Study)

This study, called the AIRTECH Study, is looking at how walking and sleeping habits affect recovery after surgery for lung cancer. Researchers want to understand if walking more after surgery can lead to fewer or less severe complications. You would either receive usual care, or usual care plus a Fitbit to track your steps. The main goal is to see if there's a difference in complications (measured by the Clavien-Dindo postoperative morbidity score) up to 30 days after surgery. This information could help doctors find new ways to improve recovery and quality of life for patients like you after lung cancer surgery. The study plans to enroll 240 participants.

Study design
This is an interventional study that will randomly assign participants to one of three groups: usual care, usual care with a Fitbit, or usual care with a Fitbit and the Fitbit app. The study plans to enroll 240 participants.
What's involved
Participants will either receive usual care or use a Fitbit to monitor step count, and some will also install and use the Fitbit app. The study also involves quality-of-life assessments and questionnaires.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome, postoperative morbidity, is measured up to 30 days after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04783168

Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study

Recruiting
NAAges 18+InterventionalSupportive care
M.D. Anderson Cancer Center
~240 participants
Updated 2026-04-16 on ClinicalTrials.gov
What's tested:Best PracticeHealth Promotion and EducationMedical Device Usage and EvaluationQuality-of-Life AssessmentQuestionnaire Administration

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Clavien-Dindo postoperative morbidity (POM) score
Measured over Up to 30 days after surgery
Lung Carcinoma
1 sites across 1 states
Texas1
  • Garrett L Walsh · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 years or older
English speaking
Ambulatory preoperatively
Patients undergoing at least a lobectomy
Must own a smart phone and be willing to install the Fitbit application (App)
Adequate internet connection via wifi or wireless network connection with smartphone
Patients who are not already using a wearable device to track daily steps

Exclusion

Medical, psychiatric, cognitive or other conditions that compromise the patient's ability to understand the patient information, to give informed consent, to comply with the study protocol or to complete the study.
Cannot maintain activity monitor in place at the time of consent
Pregnant patients
  • Clavien-Dindo postoperative morbidity (POM) scoreUp to 30 days after surgery

    Two Bayesian probability and inferential models will be utilized: * Model 1: Inferential goals: Probability that POM score in the control arm is greater than F0 or FB arm: mean and 95% Credible Interval * Model 2: Baseline covariates adjusted analysis of model 1 * Performance status * FEV1 * Age * Open vs. Minimally invasive (0 is best, 5 is worst.) 0 - No postoperative complications 1. - Minor complication resolved without intervention 2. - complication requiring pharmaceutical intervention 3. - complication requiring surgical, endoscopic or radiological intervention, 4. - life-threatening complication requiring intensive care 5. - complication leading to the patient's death.